AbCellera Biologics Inc. - SIC # -

Ticker Exchange SIC # Website Latest Ticker
ABCL Nasdaq www.abcellera.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbCellera Biologics Inc.

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 - Oct 4th, 2024 1:00 pm
AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024 - Sep 26th, 2024 8:05 pm
AbCellera Biologics Inc. (ABCL): The Best Multibagger Penny Stock of 2025? - Sep 2nd, 2024 2:26 am
Carl Hansen Buys Handful Of Shares In AbCellera Biologics - Aug 31st, 2024 12:13 pm
AbCellera to Present at Upcoming Investor Conferences in September - Aug 29th, 2024 8:05 pm
AbCellera Biologics Inc. (ABCL): A Top Contender Among Canada’s Best Penny Stocks in 2024 - Aug 29th, 2024 9:13 am
Need To Know: The Consensus Just Cut Its AbCellera Biologics Inc. (NASDAQ:ABCL) Estimates For 2024 - Aug 11th, 2024 12:21 pm
Earnings Update: AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Are Trimming Their Forecasts - Aug 9th, 2024 10:35 am
AbCellera Biologics Inc.'s (NASDAQ:ABCL) latest 12% decline adds to one-year losses, institutional investors may consider drastic measures - Aug 7th, 2024 11:43 am
AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript - Aug 7th, 2024 4:45 am
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue Estimates - Aug 6th, 2024 10:15 pm
AbCellera Reports Q2 2024 Business Results - Aug 6th, 2024 8:05 pm
AbCellera and Lilly broadens antibody discovery partnership - Aug 1st, 2024 10:32 am
AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines - Jul 31st, 2024 1:00 pm
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio? - Jul 21st, 2024 9:37 am
AbCellera Biologics (ABCL) Upgraded to Buy: Here's What You Should Know - Jul 9th, 2024 4:00 pm
AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024 - Jun 25th, 2024 8:05 pm
Down 57%, Is AbCellera Biologics a Buy on the Dip? - Jun 13th, 2024 9:40 am
We're Not Very Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn Rate - Jun 6th, 2024 11:21 am
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 - May 28th, 2024 8:05 pm